Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Autoimmune Diseases × Azathioprine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Myasthenia Gravis 2 Nervous System Diseases 1 Carcinoma, Hepatocellular 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1

Interventions

Data Collection 3 telitacicept 1 human papillomavirus vaccine, L1 type 16, 18 1 Vitamin D 1 Telemedicine 1 Plasma Exchange 1 Mycophenolic Acid 1 Immune Checkpoint Inhibitors 1 Fish Oils 1 Fatty Acids, Omega-3 1 Eicosapentaenoic Acid 1 Docosahexaenoic Acids 1 Cholecalciferol 1 CT-P13 1 Azathioprine 1 Ashwagandha 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03490539 2021-02-03

PROMISE-MG

Duke University

Autoimmune Diseases, Myasthenia Gravis, Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡